Towards a Rational Design of an Asymptomatic Clinical Herpes Vaccine: The Old, the New, and the Unknown
The best hope of controlling the herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) pandemic is the development of an effective vaccine. However, in spite of several clinical trials, starting as early as 1920s, no vaccine has been proven sufficiently safe and efficient to warrant commercial de...
Saved in:
Main Authors: | Aziz Alami Chentoufi, Elizabeth Kritzer, David M. Yu, Anthony B. Nesburn, Lbachir BenMohamed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/187585 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections
by: Aziz Alami Chentoufi, et al.
Published: (2012-01-01) -
Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines
by: Aziz A. Chentoufi, et al.
Published: (2024-12-01) -
A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters
by: Afshana Quadiri, et al.
Published: (2025-01-01) -
Unknown presentation attack detection against rational attackers
by: Ali Khodabakhsh, et al.
Published: (2021-09-01) -
A cross-sectional study exploring the predictors of herpes zoster vaccination for people aged over 50 years old in Chaoyang district, Beijing
by: Jiao Zhang, et al.
Published: (2025-01-01)